These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

830 related items for PubMed ID: 23378463

  • 21. RAPID3? Aptly named!
    Berthelot JM.
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-80-4. PubMed ID: 25365094
    [Abstract] [Full Text] [Related]

  • 22. The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy.
    Barnabe C, Homik J, Barr SG, Martin L, Maksymowych WP.
    J Rheumatol; 2014 Aug; 41(8):1607-13. PubMed ID: 25028371
    [Abstract] [Full Text] [Related]

  • 23. Assessing remission in clinical practice.
    Mierau M, Schoels M, Gonda G, Fuchs J, Aletaha D, Smolen JS.
    Rheumatology (Oxford); 2007 Jun; 46(6):975-9. PubMed ID: 17341506
    [Abstract] [Full Text] [Related]

  • 24. Performance of the 2011 ACR/EULAR preliminary remission criteria compared with DAS28 remission in unselected patients with rheumatoid arthritis.
    Thiele K, Huscher D, Bischoff S, Späthling-Mestekemper S, Backhaus M, Aringer M, Kohlmann T, Zink A, German Collaborative Arthritis Centres.
    Ann Rheum Dis; 2013 Jul; 72(7):1194-9. PubMed ID: 22915625
    [Abstract] [Full Text] [Related]

  • 25. Performance of routine assessment of patient index data 3 (RAPID3) in monitoring disease activity of Chinese rheumatoid arthritis patients.
    Zhang X, Xie A, Wang Y, Deng X, Geng Y, Ji L, Hao Y, Li G, Zhang Z.
    Int J Rheum Dis; 2018 Nov; 21(11):1940-1945. PubMed ID: 30402934
    [Abstract] [Full Text] [Related]

  • 26. Validity and reliability problems with patient global as a component of the ACR/EULAR remission criteria as used in clinical practice.
    Masri KR, Shaver TS, Shahouri SH, Wang S, Anderson JD, Busch RE, Michaud K, Mikuls TR, Caplan L, Wolfe F.
    J Rheumatol; 2012 Jun; 39(6):1139-45. PubMed ID: 22589262
    [Abstract] [Full Text] [Related]

  • 27. Validation of RAPID3 using a Japanese version of Multidimensional Health Assessment Questionnaire with Japanese rheumatoid arthritis patients: characteristics of RAPID3 compared to DAS28 and CDAI.
    Yokogawa N, Kaneko T, Nagai Y, Nunokawa T, Sawaki T, Shiroto K, Shimada K, Sugii S.
    Mod Rheumatol; 2015 Mar; 25(2):264-9. PubMed ID: 25156777
    [Abstract] [Full Text] [Related]

  • 28. Achievement of Remission and Low Disease Activity Definitions in Patients with Rheumatoid Arthritis in Clinical Practice: Results from the NOR-DMARD Study.
    Uhlig T, Lie E, Norvang V, Lexberg ÅS, Rødevand E, Krøll F, Kalstad S, Olsen IC, Kvien TK.
    J Rheumatol; 2016 Apr; 43(4):716-23. PubMed ID: 26879358
    [Abstract] [Full Text] [Related]

  • 29. GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate.
    Castrejón I, Pincus T, Soubrier M, Lin YC, Rat AC, Combe B, Dougados M.
    Rheumatology (Oxford); 2013 Oct; 52(10):1890-7. PubMed ID: 23864169
    [Abstract] [Full Text] [Related]

  • 30. Comparison of three rheumatoid arthritis disease activity scores in clinical routine.
    Rintelen B, Sautner J, Haindl PM, Andel I, Maktari A, Leeb BF.
    Scand J Rheumatol; 2009 Oct; 38(5):336-41. PubMed ID: 19585379
    [Abstract] [Full Text] [Related]

  • 31. Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.
    Aletaha D, Smolen JS.
    Arthritis Rheum; 2011 Dec; 63(12):3702-11. PubMed ID: 21953215
    [Abstract] [Full Text] [Related]

  • 32. Remission in early rheumatoid arthritis defined by 28 joint counts: limited consequences of residual disease activity in the forefeet on outcome.
    van Tuyl LH, Britsemmer K, Wells GA, Smolen JS, Zhang B, Funovits J, van Schaardenburg D, Felson D, Boers M.
    Ann Rheum Dis; 2012 Jan; 71(1):33-7. PubMed ID: 21953347
    [Abstract] [Full Text] [Related]

  • 33. The provisional ACR/EULAR definition of remission in RA: a comment on the patient global assessment criterion.
    Vermeer M, Kuper HH, van der Bijl AE, Baan H, Posthumus MD, Brus HL, van Riel PL, van de Laar MA.
    Rheumatology (Oxford); 2012 Jun; 51(6):1076-80. PubMed ID: 22302059
    [Abstract] [Full Text] [Related]

  • 34. Near misses of ACR/EULAR criteria for remission: effects of patient global assessment in Boolean and index-based definitions.
    Studenic P, Smolen JS, Aletaha D.
    Ann Rheum Dis; 2012 Oct; 71(10):1702-5. PubMed ID: 22736085
    [Abstract] [Full Text] [Related]

  • 35. Performance of Routine Assessment of Patient Index Data 3 (RAPID3) for assessment of rheumatoid arthritis in clinical practice: differential agreement of RAPID3 according to disease activity categories.
    Kim SK, Park SH, Bae J, Son JT, Choe JY.
    Rheumatol Int; 2014 Sep; 34(9):1311-8. PubMed ID: 24832679
    [Abstract] [Full Text] [Related]

  • 36. The new ACR/EULAR remission criteria: rationale for developing new criteria for remission.
    Bykerk VP, Massarotti EM.
    Rheumatology (Oxford); 2012 Dec; 51 Suppl 6():vi16-20. PubMed ID: 23221582
    [Abstract] [Full Text] [Related]

  • 37. Patient-derived joint counts are a potential alternative for determining Disease Activity Score.
    Kavanaugh A, Lee SJ, Weng HH, Chon Y, Huang XY, Lin SL.
    J Rheumatol; 2010 May; 37(5):1035-41. PubMed ID: 20156946
    [Abstract] [Full Text] [Related]

  • 38. Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study.
    Burmester GR, Ferraccioli G, Flipo RM, Monteagudo-Sáez I, Unnebrink K, Kary S, Kupper H.
    Arthritis Rheum; 2008 Jan 15; 59(1):32-41. PubMed ID: 18163417
    [Abstract] [Full Text] [Related]

  • 39. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.
    Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, Aletaha D, Allaart CF, Bathon J, Bombardieri S, Brooks P, Brown A, Matucci-Cerinic M, Choi H, Combe B, de Wit M, Dougados M, Emery P, Furst D, Gomez-Reino J, Hawker G, Keystone E, Khanna D, Kirwan J, Kvien TK, Landewé R, Listing J, Michaud K, Martin-Mola E, Montie P, Pincus T, Richards P, Siegel JN, Simon LS, Sokka T, Strand V, Tugwell P, Tyndall A, van der Heijde D, Verstappen S, White B, Wolfe F, Zink A, Boers M.
    Ann Rheum Dis; 2011 Mar 15; 70(3):404-13. PubMed ID: 21292833
    [Abstract] [Full Text] [Related]

  • 40. Prevalence of feet and ankle arthritis and their impact on clinical indices in patients with rheumatoid arthritis: a cross-sectional study.
    Lee SW, Kim SY, Chang SH.
    BMC Musculoskelet Disord; 2019 Sep 11; 20(1):420. PubMed ID: 31506089
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.